Vitalik Buterin Backs ZKsync: Is This the Next Era for Layer 2 Expansion?
- Vitalik Buterin's endorsement elevates ZKsync's Atlas upgrade as a key Ethereum Layer 2 scaling solution. - ZKsync's 15,000 TPS Atlas and upcoming 30,000 TPS Fusaka upgrades boost institutional adoption and real-time transaction capabilities. - ZK token's 65% rally faces pressure from token unlocks, while ZKsync competes with Arbitrum and Optimism for TVL and enterprise contracts. - Partnerships with Deutsche Bank and Citi highlight ZKsync's institutional traction in private transaction frameworks. - Ana
Technical Advancements: The Atlas and Fusaka Upgrades
ZKsync’s development roadmap has consistently drawn attention from both developers and investors. The Atlas upgrade, which debuted in 2025, brought a 15,000 TPS capacity and a
Recent data shows that
Tokenomics and Market Volatility: A Double-Edged Sword
The ZK token experienced a dramatic surge after Buterin’s endorsement. In Q4 2025, its price jumped 65% in a week, fueled by his support and proposed changes to tokenomics,
Bitget analysts point out that ZKsync’s “ZKnomics” approach aims to link token value with network activity,
Institutional Adoption: From Banks to Enterprise
Interest from institutional players in ZKsync has soared since Buterin’s endorsement.
By late 2025, ZKsync had formed partnerships with financial institutions looking for scalable, cost-effective solutions for cross-border payments and asset tokenization
Competitive Landscape: ZKsync vs. Arbitrum and Optimism
Despite ZKsync’s impressive technical progress, its investment prospects must be weighed against its main competitors. Arbitrum, with $12 billion in TVL and 1.5 million daily transactions,
ZKsync’s edge comes from its ZK Stack and traction with institutions. The Fusaka upgrade’s promise to boost throughput to 30,000 TPS could help it close the gap with Arbitrum, but there are still execution risks. As one analyst put it, “ZKsync’s future depends on turning its technical strengths into widespread adoption—something Arbitrum has already achieved at scale
Analyst Outlook: Price Predictions and Scenarios
Bitget’s research team has outlined three possible paths for ZK’s price in 2025. In a bullish scenario, where Ethereum Layer 2 solutions see rapid adoption and ZKsync lands major partnerships, the token could climb to $0.40–$0.60. A moderate outcome would see prices between $0.20–$0.35, while a bearish scenario could push it down to $0.10–$0.15 if market sentiment worsens or ZKsync fails to stand out
These forecasts highlight the token’s volatility but also its potential for significant gains or losses. The main factors—Fusaka’s rollout, institutional uptake, and broader Ethereum upgrades—will ultimately decide if ZKsync becomes a key player in Layer 2 scaling or fades from prominence.
Conclusion: A Calculated Bet on ZK's Future
Vitalik Buterin’s backing has undoubtedly raised ZKsync’s profile, but the investment case is still complex. While the platform’s technical progress and institutional interest are promising, its relatively small TVL and stiff competition from established players like Arbitrum and Optimism remain significant challenges. For investors, the crucial question is whether ZKsync can turn Buterin’s endorsement into lasting adoption and ecosystem growth.
With the Fusaka upgrade approaching and Ethereum’s scaling efforts advancing, ZKsync faces a pivotal moment. If it can fulfill its promises, it could become a leading Layer 2 solution. Yet, in the unpredictable world of blockchain, even the most promising projects are not guaranteed success.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea's Approach to Crypto Regulation Could Become a Model for Global Stability and Innovation
- South Korea's Digital Asset Basic Act (2025) establishes a unified regulatory framework for crypto assets, targeting stablecoins and cross-border transactions. - Stablecoin issuers face licensing, reserve requirements, and FSC oversight, while foreign VASPs must register and report transactions to combat forex crimes. - The reforms aim to balance innovation with financial stability, potentially attracting investment but increasing compliance costs for firms and scrutiny for investors. - As Asia's major c

Ethereum News Update: Ethereum Whale Makes $1.33B Leveraged Move—Sign of Confidence or Risky Overextension?
- Ethereum whale "66kETHBorrow" injected $1.33B into ETH via leveraged Aave borrowing, stabilizing prices near $3,500. - Whale's 385k ETH holdings and $270M Aave-funded purchases signal institutional confidence despite market volatility. - Analysts note leveraged accumulation often precedes recoveries, though risks include amplified losses if prices correct further. - Market remains divided as whale's strategy contrasts with $183M Ethereum ETF outflows and key support/resistance levels.
Algorand (ALGO) Falls 54.47% Over the Past Year as Company Developments and Market Challenges Persist
- Algorand (ALGO) fell 54.47% in one year due to macro pressures and lack of product milestones. - Biopharma firms Aligos and Allogene announced stock incentives/insider transactions unrelated to crypto. - Prolonged crypto bear market and weak adoption left ALGO vulnerable to sector-wide declines. - Investors await Algorand Foundation updates amid ongoing volatility and uncertain valuation metrics.

Lloyds Completes Curve Purchase Amid Shareholder Disputes Over Valuation
- Lloyds acquires Curve for £120M amid shareholder backlash over undervaluation and governance concerns. - IDC Ventures, Curve's largest investor, rejects the deal via legal action, disputing transparency and valuation. - Lloyds aims to integrate Curve's payment tech to compete with Apple/Google Pay amid EU regulatory shifts. - The acquisition reflects fintech consolidation as banks exploit lower valuations to fast-track digital infrastructure. - Legal challenges and governance disputes could delay the dea
